Evaluation of the generation of genotoxic and cytotoxic metabolites of benzo[a]pyrene,aflatoxin B1,naphthalene and tamoxifen using human liver microsomes and human lymphocytes

Abstract

1 The ability of model stable epoxides and metabolites generated by human liver microsomes from benzo[a]pyrene, aflatoxin B₁, naphthalene and tamoxifen to produce cytotoxicity and genotoxicity in human periph eral lymphocytes has been investigated.

2 The stable epoxides 1,1,1 trichloropropene-2,3-oxide (100μM) and trans stilbene oxide (100μM) as well as metabolites generated from aflatoxin B₁ (30μM) and naph thalene (100μM) by an extracellular metabolising system were toxic to isolated resting mononuclear leucocytes (MNLs), whereas glycidol (100μM), benzo[a]pyrene (100μM) and tamoxifen (50μM) were not.

3 The stable epoxides 1,1,1 trichloropropene-2,3-oxide (100μM) and trans stilbene oxide (100μM) but not glycidol (100μM) were toxic to dividing lymphocytes only after a 72-h exposure. Tamoxifen (30μM), aflatoxin B₁ (30μM) and their metabolites were also toxic to dividing lymphocytes. Benzo[a]pyrene (100μM) and naphthalene (100/μM) were not toxic either in the absence or presence of the extracel lular metabolising system.

4 Benzo[a]pyrene (100/μM) and aflatoxin B₁ (30μM) were directly genotoxic to lymphocytes, this genotoxicity was significantly enhanced by the presence of the extracellular metabolising system. This indicates that both intracellular and extracellular bioactivation of these two compounds can produce genotoxicity. In contrast, naphthalene and tamoxifen were non-genotoxic.

Keywords

epoxides benzo[a]pyrene aflatoxin B1 naph thalene tamoxifen liver lymphocytes

Get full access to this article

View all access options for this article.

References

Ames B. , McCann J. & Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutation Research 1975; 31: 347-64.

Pirmohamed M. , Kitteringham NR , Guenther TM , Breckenridge AM & Park BK Investigation into the formation of cytotoxic, protein reactive and stable metabolites from carbamazepine in vitro. Biochemical Pharmacology 1992; 43: 1675-82.

Pirmohamed M. , Graham A. , Roberts P. , Smith D. , Chadwick D. , Breckenridge AM & Park BK Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxycarbazepine . British Journal of Clinical Pharmacology 1991; 32: 741-9.

Perry P. & Wolf S. New giemsa method for the differential staining of sister chromatids. Nature 1974; 251: 156-8.

Buckpitt AR & Warren DL Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 8-16.

Parry JM Prediction of the carcinogenic potential of chemicals. Mutagenesis 1992: 7: 1-2.

Tingle MD , Pirmohamed M. , Templeton E. et al. An investigation of the formation of cytotoxic, genotoxic, protein reactive and stable metabolites from naphthalene by human liver in vitro. Biochemical Pharmacology 1993; 46: 1529-38.

White Inh , De Matteis F. , Davies A. , Smith LL , Crofton-Sleigh C. , Venitt S. , Hewer A. & Phillips DH Genotoxic potential of tamoxifen and analogues in female Fisher F355/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis 1992: 13: 2197-203.

Styles JA , Davies A. , Lim CK , De Matteis F. , Stanley LA , White Inh , Yuan ZX & Smith LL Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis 1994; 15: 5-9.

10.

Purba HS , Maggs JL , Orme ML'E, Back DJ & Park BK. The metabolism of 17 α ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites . British Journal of Clinical Pharmacology 1987; 23: 447-53.

11.

Lowry OH , Rosebrough NJ , Farr AL & Randall RJ Protein measurement with the Folin phenol reagent. Journal Biological Chemistry 1951; 193: 265-79.

12.

Riley RJ , Lambert C. , Maggs JL , Kitteringham NR & Park BK An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. British Journal of Clinical Pharmacology 1988; 26: 577-88.

13.

Spielberg SP Acetaminophen toxicity in human lymphocytes in vitro. Journal Pharmacology and Experimental Therapeutics 1980; 213: 395-8.

14.

Dean BJ & Danford N. Chemically induced chromosome damage. In: Mutagenicity testing: a practical approach, Venitt S & Parry JM (eds), pp. 187-232. IRL Press: Oxford, 1984.

15.

Goto K. , Maeda S. , Kano Y. & Sugiyama T. Factors involved in differential Giemsa staining of sister chromatids. Chromosoma 1978; 66: 351-9.

16.

Norppa H. , Hemminki K. , Sorsa H. & Vainio H. Effect of monosubstituted epoxides on chromosome abberations and SCE in cultured human lymphocytes. Mutation Research 1981; 91: 241-50.

17.

Wiencke JK , Kelsy KT , Lamela RA & Tascano WA Human glutathione S transferase deficiency as a marker of susceptibility to epoxide induced cytogenetic damage. Cancer Research 1990; 50: 1585-90.

18.

Phillips DH , Hewer A. , White Inh & Farmer PB Co-chromatography of a tamoxifen epoxidedeoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats. Carcinogenesis 1994; 15: 793-5.

19.

Takehisa S. Induction of sister-chromatid exchanges by chemical agents. In: Sister chromatid exchanges. Wolff S (ed). p.117. Wiley Interscience: USA, 1982.

20.

Guengerich FP and Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology 1991, 4: 391-407.

21.

Grover PL , Sims P. , Mitschley Bcv & Roe Fjc. The carcinogenicity of polycyclic hydrocarbon epoxides in new born mice. British Journal Cancer 1975; 31: 182.

22.

Forrester LM , Neal GE , Judah DJ , Glancey MJ & Wolf CR Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc Natl Acad Sci USA 1990; 87: 8306-10.

23.

Busby Jr WF & Wogan GN. Aflatoxins. In Chemical carcinogens Searle CE , (ed). pp. 945-1136. American Chemical Society: Washington DC, 1984.

24.

Rudiger HW , Kohl F. , Mangels W. , von Wichert P. , Bartram CR , Wöhler W. & Passarge E. Benzpyrene induces sister chromatid exchanges in cultured lymphocytes. Nature 1976; 262: 290-2.

25.

Gautier JC , Urban P. , Beaune P. & Pompon D. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the first steps of benzo[a]pyrene activation . European Journal of Biochemistry 1993, 211: 63-72.

26.

Oesch F. , Jerina DM & Daly JW

Substrate specificity of hepatic epoxide hydrase in microsomes and in purified preparation: Evidence for homologous enzymes. Archives of Biochemistry and

Biophysics 1971 ; 144: 253-61.

27.

Cho M. , Chichester C. , Morin D. , Plopper C. & Buckpitt A. Covalent binding of reactive naphthalene metabolites with protein. Journal of Pharmacology and Experimental Therapeutics 1994 ; 269: 881-9.

28.

Lui YH , Taylor J. , Linko P. , Lucier GW & Thompson CL Glutathione S transferase in human lymphocytes and liver, role in modulating formation of carcinogen derived DNA adducts. Carcinogenesis 1991; 12: 2269-75.

29.

Tucker MJ , Adam KK & Patterson JS Tamoxifen. In: Safety testing of new drugs, Laurence DR , Mclean AEM & Weatherall M (eds), pp. 125-61, Academic Press: New York, 1984.

30.

Inoue K. , Shibata T. & Abe T. Induction of sister-chromatid exchanges in human lymphocytes by indirect carcinogens with and without metabolic activation. Mutation Research 1983; 117: 301-9.